000 03220nam a22003735i 4500
001 86838
003 ES-MaUEC
005 20230214040159.0
007 cr nn 008mamaa
008 160604s2016 si | s |||| 0|eng d
020 _a9789811008184
040 _aES-MaUEC
050 4 _aR857.N34
_bN368 2016 EB
082 0 4 _a610.28
245 0 0 _aNanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration
_cedited by Sudesh Kumar Yadav
260 _aSingapore
_bSpringer
_c2016
300 _a1 recurso en línea (XIX, 172 p.) 11 il., 10 il. col.
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
338 _aonline resource
_bcr
_2rdacarrier
505 0 _a1. Nanoscale materials in targeted drug delivery -- 2. Biodegradable nanoparticles and their in vivo fate -- 3. Metallic nanoparticles, toxicity issues and applications in medicine -- 4. Liposomal and phytosomal formulations -- 5. Nanocellulose and nanocomposites -- 6. Theragnosis: Nanoparticles as a tool for simultaneous therapy and diagnosis -- 7. Cellular response of therapeutic nanoparticles.
520 _aThis book is the first of its kind to offer a comprehensive and up-to-date discussion of the use of nanoscale materials for biomedical applications, with a particular focus on drug delivery, theragnosis and tissue regeneration. It also describes in detail the methods used in the preparation of nanoparticles. Response of nanoparticles in biological systems are also explored. Nanotechnology has led to the advent of a new field, nanomedicine, which focuses on the use of nanomaterials as drug-delivery vehicles to develop highly selective and effective drugs. The combination of molecular imaging and nanotechnology has produced theragnostic nanoparticles, which allow the simultaneous detection and monitoring of diseases. Nanotechnology can also be combined with biomaterials to create scaffolds for tissue regeneration. Further, significant advances have been made in the areas of drug delivery, theragnostic nanoparticles and tissue regeneration materials. Some nanomedicines and tissue regeneration materials are already commercially available, while others are undergoing clinical trials, and promising results have been documented. Despite the rapid advances in nanomedicine, there is a relative dearth of literature on the biomedical applications of nanoscale materials.
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGER
650 7 _aNanotecnología
_0comprobar BNE20011268513
_2embne
_9158453
650 7 _9143820
_aIngeniería biomédica
_0comprobar BNE19902550170
_2embne
700 1 _aYadav, Sudesh Kumar.
_eeditor literario
_9100868
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-981-10-0818-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9789811008184
907 _a.b12961164
_b10-10-17
_c21-11-16
998 _am
_a_alco
_a_vill
_b16-09-17
_cm
_dz
_ef
_feng
_gsi
_h0
945 _aR857 .N34 N368 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11602016
_z06-04-17
999 _c86838
_d86838
_x1